Guardant Health
GH
#1160
Rank
NZ$35.45 B
Marketcap
NZ$267.38
Share price
-1.60%
Change (1 day)
213.02%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$3.70 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are NZ$3.70 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$3.64 B26.6%
2024-12-31NZ$2.88 B11.96%
2023-12-31NZ$2.57 B5.44%
2022-12-31NZ$2.44 B6.91%
2021-12-31NZ$2.28 B79.81%
2020-12-31NZ$1.26 B646.59%
2019-12-31NZ$0.17 B82.67%
2018-12-31NZ$93.1 M92.6%
2017-12-31NZ$48.34 M-9.18%
2016-12-31NZ$53.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Neogen
NEOG
NZ$2.22 B-40.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ$1.48 B-59.91%๐Ÿ‡บ๐Ÿ‡ธ USA